pharmacogenomics - American Pharmacogenomics Association

The Rise of Polygenic Risk Scores: Can PGx Predict Susceptibility to Medication Side Effects?

Posted onJune 11, 2024June 11, 2024

Explore how Polygenic Risk Scores enhance personalized medicine by predicting medication side effects and disease susceptibility.

Posted onMay 27, 2024June 11, 2024

Explore how PGx and Factor V Leiden intertwine to influence medication efficacy and safety for those with genetic clotting disorders.

Posted onMay 18, 2024June 11, 2024

Discover how CYP2C9 genetic variations impact warfarin sensitivity and can guide personalized anticoagulant therapy for better patient outcomes.

Gated Content

Posted onMay 13, 2024May 13, 2024

Uncover how preemptive genetic testing for TPMT and NUDT15 can guide safer drug use and individualized patient care.

APGxA

Posted onApril 22, 2024April 22, 2024

Discover why some medications may not work for you through pharmacogenomics, the key to personalized medicine and better drug efficacy.

Gated Content

Posted onApril 15, 2024

Explore how altering drug targets is reshaping therapeutic approaches and enhancing receptor and enzyme efficacy in modern medicine.

Posted onApril 15, 2024June 11, 2024

Explore how pharmacogenomics optimizes clopidogrel efficacy for heart and stroke prevention, ensuring personalized blood clot management.

End of content